T-cell Prolymphocytic Leukemia (T-PLL)
T-cell Prolymphocytic Leukemia (T-PLL) is the indication for 1 drug in DrugBank. It is covered by 1 curated, structured indication.
- Also known as
- Leukemia, Prolymphocytic, T-Cell · T-cell prolymphocytic leukaemia · T-Cell Prolymphocytic Leukemia · T-cell-prolymphocytic Leukemia · T-Prolymphocytic Leukemia
- Classified under
- Indicated drugs
Resolves to
Vocabularies
What you can answer from here — as of October 25, 2026
Which approved drugs for T-cell Prolymphocytic Leukemia (T-PLL) share a target, and which companies have late-stage candidates against it?
Create a free account or log in to explore the full data card.
Create Account